Internal Medicine

3151 questions

Question 1781Question →

For each patient presenting with renal dysfunction, identify the characteristic microscopic urine sediment finding that would most strongly support the underlying diagnosis.

Click a left item, then click its matching right item

Items

A 54-year-old male who develops an abrupt decline in renal function 48 hours after surviving profound hypovolemic shock due to a ruptured splenic artery aneurysm.
A 25-year-old female presenting with recent-onset hypertension, periorbital swelling, and tea-colored urine two weeks after recovering from a severe sore throat.
A 42-year-old male who develops an acute rise in serum creatinine, a diffuse maculopapular skin eruption, and a low-grade fever five days into a course of nafcillin.
A 58-year-old male exhibiting massive bilateral lower extremity edema, a serum albumin of 2.2 g/dL, and a 24-hour urine protein excretion of 5.2 grams.
A 72-year-old female with a 30-year history of inadequately controlled type 2 diabetes mellitus now presenting with an estimated glomerular filtration rate of 11 mL/min/1.73 m².

Matches

Show answer & explanation

Answer

The clinical scenarios map to their respective urinary sediment findings as follows: Ischemic ATN with muddy brown casts, Post-infectious GN with RBC casts, AIN with WBC casts, Nephrotic syndrome with fatty casts, and advanced CKD with broad waxy casts.
Each microscopic urinalysis finding acts as a distinct biomarker for the underlying pathophysiology. Granular (muddy brown) casts reflect desquamated tubular cells in ATN. RBC casts denote glomerular bleeding. WBC casts and eosinophils indicate allergic interstitial inflammation. Fatty casts occur when filtered lipoproteins are processed by tubular cells in nephrotic syndrome. Broad waxy casts form in the dilated, hypertrophic tubules of chronically diseased kidneys.

Step-by-Step Solution

1
Analyze the etiology of the 54-year-old male with shock-induced AKI.
Hypotension causes renal ischemia leading to Acute Tubular Necrosis (ATN).
ATN is characterized by the death and sloughing of tubular cells, which aggregate into muddy brown casts.
2
Evaluate the 25-year-old female with post-pharyngitis nephritic symptoms.
Presentation is consistent with post-infectious glomerulonephritis.
Glomerular inflammation leads to bleeding into the Bowman's space, forming RBC casts as they travel down the tubules.
3
Assess the 42-year-old male with fever, rash, and AKI after nafcillin use.
The classic allergic triad strongly suggests drug-induced Acute Interstitial Nephritis (AIN).
AIN causes an allergic inflammatory infiltrate in the interstitium, releasing WBCs and eosinophils into the urine.
4
Determine the syndrome for the 58-year-old male with massive edema and heavy proteinuria.
Proteinuria > 3.5 g/day confirms Nephrotic Syndrome.
Heavy proteinuria triggers hepatic lipoprotein synthesis; these lipids enter the urine forming fatty casts and oval fat bodies.
5
Interpret the 72-year-old female with long-standing diabetes and GFR of 11.
The presentation denotes End-Stage Renal Disease (ESRD) / advanced Chronic Kidney Disease.
Chronic structural damage leads to dilated tubules and low flow states, causing the formation of broad, waxy casts.

Key Concept

Correlation of microscopic urinalysis sediment findings with specific nephrologic pathophysiologies.
Question 1782Question →

A 54-year-old man is evaluated in the hospital on hospital day 3 for ongoing management of a severe skin and soft tissue infection of the right lower extremity. He initially presented with high fever, chills, and a rapidly expanding area of erythema and induration. Blood cultures drawn on admission have now returned positive for methicillin-susceptible Staphylococcus aureus (MSSA). His empiric antimicrobial regimen since admission has consisted of intravenous vancomycin and cefepime. The patient's medical record indicates an allergy to penicillin, which he describes as a flat, red rash on his chest that occurred 20 years ago when taking amoxicillin. He explicitly denies any history of facial swelling, hives, or breathing difficulties. He is currently hemodynamically stable, his temperature is 37.4°C (99.3°F), and the erythema has significantly receded. Subsequent blood cultures drawn 48 hours after admission show no growth to date.

Which of the following is the most appropriate pharmacologic intervention at this time?

Show answer & explanation

Answer: Replace the current antimicrobials with intravenous cefazolin

Answer

Replace the current antimicrobials with intravenous cefazolin
The patient has MSSA bacteremia secondary to a skin and soft tissue infection. The drug of choice for MSSA bacteremia is an anti-staphylococcal beta-lactam, such as cefazolin or nafcillin, because these agents have been shown to provide superior clinical outcomes, faster bacterial clearance, and lower mortality compared to vancomycin. A critical decision point in this vignette is the patient's reported penicillin allergy. He experienced a non-pruritic maculopapular rash to amoxicillin 20 years ago. This is a classic non-IgE-mediated, delayed-type hypersensitivity reaction that is generally benign. Furthermore, cefazolin has a unique R1 side chain that is structurally distinct from other penicillins and cephalosporins, making the rate of cross-reactivity virtually non-existent. Therefore, the most appropriate next step in antibiotic stewardship is to de-escalate his broad-spectrum empiric regimen and transition him to intravenous cefazolin monotherapy.

Step-by-Step Solution

1
Analyze the culture and susceptibility results.
The pathogen is identified as methicillin-susceptible Staphylococcus aureus (MSSA).
Guides targeted antimicrobial de-escalation from empiric broad-spectrum therapy.
2
Evaluate the patient's penicillin allergy history.
The history of a flat, red rash 20 years ago indicates a delayed, non-IgE-mediated reaction rather than anaphylaxis.
Determines the safety of administering beta-lactam antibiotics, which are the treatment of choice for MSSA.
3
Select the optimal targeted therapy for MSSA bacteremia.
Intravenous cefazolin is selected as the definitive therapy.
Anti-staphylococcal beta-lactams are superior to vancomycin for MSSA, and cefazolin poses virtually zero cross-reactivity risk given its unique side chain.

Key Concept

Patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia should be treated with an anti-staphylococcal beta-lactam (e.g., cefazolin, nafcillin) rather than vancomycin due to superior clinical outcomes. A remote, non-IgE-mediated penicillin allergy is not a contraindication to cefazolin.
Estimated Time:1m 15s
Question 1783Question →

A 20-year-old woman is brought to the emergency department by her roommate due to confusion, nausea, and ringing in her ears for the past 6 hours. The patient has a history of major depressive disorder and recently went through a difficult breakup. On physical examination, she is diaphoretic and mildly disoriented. Temperature is 38.2°C (100.8°F), blood pressure is 115/75 mm Hg, pulse is 116/min, and respirations are 30/min. Lungs are clear to auscultation.

Laboratory studies show:

ParameterResult
Serum sodium140 mEq/L
Serum potassium3.6 mEq/L
Serum chloride103 mEq/L
Serum bicarbonate13 mEq/L
Blood urea nitrogen16 mg/dL
Serum creatinine0.9 mg/dL

Arterial blood gas on room air:

ParameterResult
pH7.42
pCO220 mm Hg
pO296 mm Hg

Which of the following best describes this patient's acid-base disturbance?

Show answer & explanation

Answer: Mixed primary anion gap metabolic acidosis and primary respiratory alkalosis

Answer

Mixed primary anion gap metabolic acidosis and primary respiratory alkalosis
The patient's presentation with tinnitus, tachypnea, fever, and confusion following a difficult breakup is classic for acute salicylate (aspirin) overdose. This toxicity classically causes a mixed acid-base disorder. First, calculate the anion gap: Na+−(Cl−+HCO3−)Na^+ - (Cl^- + HCO_3^-) = 140−(103+13)=24140 - (103 + 13) = 24 mEq/L. Because this is greater than the normal range of 8-12 mEq/L, there is a primary anion gap metabolic acidosis (driven by uncoupled oxidative phosphorylation and accumulation of organic acids). Next, determine if the respiratory compensation is appropriate by using Winter's formula: Expected pCO2=1.5×13+8±2=27.5±2pCO_2 = 1.5 \times 13 + 8 \pm 2 = 27.5 \pm 2 (25.5 to 29.5 mm Hg). The patient's actual pCO2pCO_2 is 20 mm Hg. Because the actual pCO2pCO_2 is lower than the expected compensatory range, she has an excessive respiratory drive, indicating a concomitant primary respiratory alkalosis (caused by salicylates directly stimulating the medullary respiratory center). Therefore, this is a mixed primary anion gap metabolic acidosis and primary respiratory alkalosis.

Step-by-Step Solution

1
Calculate the anion gap to determine the primary metabolic disturbance.
Anion Gap = Na+−(Cl−+HCO3−)Na^+ - (Cl^- + HCO_3^-) = 140−(103+13)140 - (103 + 13) = 2424 mEq/L.
An elevated anion gap (normal 8-12 mEq/L) establishes the presence of a primary anion gap metabolic acidosis.
2
Apply Winter's formula to determine the expected respiratory compensation.
Expected pCO2=1.5×[HCO3−]+8±2pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2 = 1.5×13+8±21.5 \times 13 + 8 \pm 2 = 27.5±227.5 \pm 2 (range 25.5 to 29.5 mm Hg).
In a metabolic acidosis, the respiratory system compensates by increasing ventilation to lower the pCO2pCO_2. Winter's formula calculates the precise expected limit of this compensation.
3
Compare the actual measured pCO2pCO_2 to the expected pCO2pCO_2 range.
The patient's actual pCO2pCO_2 (20 mm Hg) is significantly lower than the expected range (25.5 - 29.5 mm Hg).
Because the pCO2pCO_2 is driven down further than metabolic compensation alone would cause, a concomitant primary respiratory alkalosis must also be present.

Key Concept

Salicylate toxicity classically presents with a mixed primary anion gap metabolic acidosis (due to uncoupled oxidative phosphorylation) and primary respiratory alkalosis (due to direct stimulation of the medullary respiratory center). This is diagnosed by identifying an elevated anion gap and noting that the actual pCO2pCO_2 is lower than the predicted range using Winter's formula.
Question 1784Question →

A 6666-year-old man is brought to the emergency department by his daughter due to a 33-day history of progressively worsening shortness of breath and a persistent cough. He notes his baseline morning cough has increased in frequency, and his sputum has changed from clear to thick and yellowish-green. His medical history is significant for severe chronic obstructive pulmonary disease (COPD), hypertension, and hypothyroidism (managed with levothyroxine). He has a 4545-pack-year smoking history. His temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), pulse is 114/min114/\text{min}, blood pressure is 145/88 mm Hg145/88\text{ mm Hg}, respiratory rate is 28/min28/\text{min}, and oxygen saturation is 86%86\% on room air.

Physical examination reveals a barrel-shaped chest with accessory muscle use. Pulmonary auscultation demonstrates a prolonged expiratory phase, diffuse expiratory wheezes, and scattered rhonchi, but no crackles are heard. The jugular venous pressure is elevated at 10 cm H2O10\text{ cm H}_2\text{O}. Abdominal examination shows a liver edge that is palpable 3 cm3\text{ cm} below the right costal margin and is mildly tender. Trace bilateral lower extremity pitting edema is present.

Laboratory studies show:
Leukocyte count: 11,500/mm311,500/\text{mm}^3
Serum sodium: 139 mEq/L139\text{ mEq/L}
Serum potassium: 4.1 mEq/L4.1\text{ mEq/L}
Serum bicarbonate: 31 mEq/L31\text{ mEq/L}
Blood urea nitrogen: 18 mg/dL18\text{ mg/dL}
Serum creatinine: 0.9 mg/dL0.9\text{ mg/dL}
Thyroid-stimulating hormone (TSH): 0.2 \muU/mL0.2\text{ \mu U/mL} (Normal: 0.4−4.0 \muU/mL0.4-4.0\text{ \mu U/mL})
Free T4: 1.2 ng/dL1.2\text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL})

Arterial blood gas analysis on room air shows a pH of 7.317.31, PaCO2\text{PaCO}_2 of 62 mm Hg62\text{ mm Hg}, and PaO2\text{PaO}_2 of 54 mm Hg54\text{ mm Hg}.

Chest radiography reveals hyperinflated lung fields, flattened diaphragms, and an enlarged right descending pulmonary artery. There are no pleural effusions or focal alveolar opacities.

Which of the following is the most appropriate next step in management for this patient?

Show answer & explanation

Answer: Inhaled albuterol and ipratropium, systemic glucocorticoids, and oral azithromycin

Answer

The most appropriate management is the administration of inhaled albuterol and ipratropium, systemic glucocorticoids, and a macrolide antibiotic such as oral azithromycin.
The correct approach targets the primary pathophysiology of an acute chronic obstructive pulmonary disease (COPD) exacerbation. This patient presents with all three cardinal symptoms (increased dyspnea, increased sputum volume, and increased sputum purulence) requiring the standard triad of therapy: short-acting bronchodilators (albuterol and ipratropium) to relieve bronchospasm, systemic glucocorticoids to reduce airway inflammation, and an antibiotic (such as a macrolide or respiratory fluoroquinolone) to treat the likely bacterial trigger. Although the patient has signs of fluid overload, these are due to cor pulmonale (right-sided heart failure secondary to chronic pulmonary hypertension) rather than left-sided heart failure, making aggressive diuresis incorrect and potentially harmful.

Step-by-Step Solution

1
Analyze the patient's acute respiratory presentation and history.
The patient has a history of COPD and presents with the classic triad of an acute exacerbation: increased dyspnea, increased sputum volume, and increased sputum purulence.
Identifying the primary acute pathology is required to guide immediate life-saving therapy.
2
Differentiate the cause of the fluid overload signs (elevated JVP, hepatomegaly).
The physical exam shows right-sided fluid overload but no left-sided fluid overload (lungs lack crackles, CXR lacks pulmonary edema). This indicates cor pulmonale due to chronic hypoxia, not acute decompensated left heart failure.
Distinguishing right heart failure from left heart failure ensures the correct pathology (lungs vs. left ventricle) is targeted.
3
Interpret the arterial blood gas (ABG) and endocrine labs in context.
The ABG shows acute-on-chronic respiratory acidosis, requiring bronchodilators to improve ventilation. The low TSH with normal Free T4 represents euthyroid sick syndrome, requiring no intervention.
Accurate interpretation of confounding laboratory abnormalities prevents the administration of inappropriate and potentially harmful treatments.

Key Concept

Management of acute COPD exacerbation complicated by cor pulmonale
Question 1785Question →

A thirty-five-year-old female is referred for endocrinologic evaluation due to progressive central weight gain, severe exhaustion, proximal muscle weakness, and easy bruising over the past seven months. Physical examination reveals a blood pressure of 162/98162/98 mm Hg, marked facial plethora, supraclavicular fat accumulation, and broad, violaceous abdominal striae. Arrange the following interventions in the most appropriate chronological sequence for the complete diagnostic workup and definitive management of this condition. Assume the patient ultimately has pituitary-dependent hypercortisolism, but any causative lesion identified on initial imaging is <5< 5 mm in diameter.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: (1) 1-mg overnight dexamethasone suppression test, (2) Plasma ACTH measurement, (3) Pituitary MRI, (4) Inferior petrosal sinus sampling (IPSS), and (5) Transsphenoidal surgery.
The evaluation of Cushing syndrome requires a rigorous, stepwise approach to prevent diagnostic errors. First, endogenous hypercortisolism must be confirmed, typically using a 1-mg overnight dexamethasone suppression test, 24-hour urine free cortisol, or late-night salivary cortisol. Once confirmed, the next step is measuring plasma ACTH to determine if the disease is ACTH-dependent (normal/elevated ACTH) or ACTH-independent (suppressed ACTH). For ACTH-dependent disease, a pituitary MRI is performed. Because incidental, non-functioning pituitary microadenomas are common in the general population, finding a lesion smaller than 6 mm on MRI is insufficient for diagnosis. In such cases, bilateral inferior petrosal sinus sampling (IPSS) with CRH stimulation must be performed to definitively confirm that the pituitary is the source of excess ACTH (Cushing disease) rather than an ectopic source. Finally, once a central source is biochemically confirmed by a central-to-peripheral ACTH gradient, transsphenoidal surgical resection is the definitive treatment.

Step-by-Step Solution

1
Establish the presence of endogenous hypercortisolism
The 1-mg overnight dexamethasone suppression test is performed as an initial screen.
Before determining the etiology, pathologic hypercortisolism must be biochemically confirmed to rule out normal physiology or pseudo-Cushing states.
2
Determine ACTH dependence
Early morning plasma ACTH concentration is measured.
This distinguishes between ACTH-independent (adrenal) and ACTH-dependent (pituitary or ectopic) sources of hypercortisolism.
3
Localize the source of ACTH production
A high-resolution MRI of the pituitary gland is obtained.
For ACTH-dependent disease, the pituitary is the most common source, making MRI the first-line imaging modality.
4
Confirm central ACTH secretion when imaging is equivocal
Bilateral IPSS with CRH stimulation is performed.
Since up to 10% of healthy individuals have incidental pituitary microadenomas, an adenoma < 6 mm is not definitive proof of Cushing disease. IPSS is required to rule out an ectopic source.
5
Provide definitive therapy
Transsphenoidal surgical resection is performed.
Once the central source is biochemically confirmed via IPSS, surgical removal of the adenoma is the treatment of choice.

Key Concept

The diagnostic algorithm for Cushing syndrome proceeds strictly from biochemical confirmation, to determining ACTH dependence, to anatomic localization, and finally to resolving imaging ambiguity with venous sampling before surgery.
Estimated Time:2m 30s
Question 1786Question →

Match each clinical presentation with the most likely corresponding coagulation panel findings.

Click a left item, then click its matching right item

Items

A 14-year-old boy with a history of recurrent hemarthroses following minor trauma and a maternal uncle with a severe bleeding disorder
A 22-year-old woman presenting with prolonged epistaxis, easy bruising, and a history of heavy menstrual bleeding since menarche
A 65-year-old man in the intensive care unit with gram-negative bacteremia who develops diffuse oozing from venipuncture sites
A 58-year-old man taking chronic medication for a mechanical aortic valve who presents with a large, spontaneous flank hematoma

Matches

Show answer & explanation

Answer

Hemophilia matches with isolated prolonged aPTT. von Willebrand disease matches with prolonged aPTT and prolonged bleeding time. Disseminated intravascular coagulation matches with globally prolonged coagulation times and consumptive markers (decreased platelets and fibrinogen). Vitamin K antagonism matches with isolated prolonged PT.
Each underlying clinical condition produces a distinct and predictable pattern of laboratory abnormalities based on the specific phase of hemostasis that is disrupted.

Step-by-Step Solution

1
Analyze the first clinical vignette (14-year-old boy).
Identify a sex-linked bleeding disorder affecting deep tissues (hemarthrosis), indicating Hemophilia.
Hemophilia A and B are intrinsic pathway factor deficiencies that manifest with deep tissue and joint bleeding.
2
Determine the laboratory profile for Hemophilia.
Matches with prolonged aPTT, normal PT, and normal bleeding time.
Deficiencies in factors VIII or IX specifically prolong the intrinsic pathway measurement (aPTT) without affecting primary platelet plug formation.
3
Analyze the second clinical vignette (22-year-old woman).
Identify a mucosal bleeding pattern (menorrhagia, epistaxis), indicating von Willebrand disease.
von Willebrand disease affects primary hemostasis and factor VIII stabilization.
4
Determine the laboratory profile for von Willebrand disease.
Matches with prolonged bleeding time and prolonged aPTT, with normal PT.
Impaired platelet adhesion prolongs bleeding time, and reduced factor VIII prolongs aPTT.
5
Analyze the third clinical vignette (ICU patient with bacteremia).
Identify a consumptive coagulopathy indicative of disseminated intravascular coagulation (DIC).
Sepsis triggers systemic, uncontrolled coagulation activation.
6
Determine the laboratory profile for disseminated intravascular coagulation.
Matches with prolonged PT, prolonged aPTT, decreased platelet count, and decreased fibrinogen.
Systemic consumption universally depletes all coagulation factors, fibrinogen, and platelets.
7
Analyze the fourth clinical vignette (patient with mechanical valve).
Identify the use of a vitamin K antagonist (warfarin) causing supratherapeutic bleeding.
Patients with mechanical valves require chronic anticoagulation, typically managed with warfarin.
8
Determine the laboratory profile for vitamin K antagonism.
Matches with prolonged PT, normal or mildly prolonged aPTT, and normal bleeding time.
Warfarin rapidly depletes factor VII, markedly prolonging the extrinsic pathway measurement (PT).

Key Concept

Differentiation of coagulation disorders requires analyzing both the coagulation cascade (PT and aPTT) and primary hemostasis mechanisms (platelet count and bleeding time).
Question 1787Question →

A 42-year-old man presents to the emergency department with a 3-day history of severe nausea, nonbilious vomiting, and diffuse abdominal pain. He has a history of poorly controlled type 1 diabetes mellitus. His temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 90/60 mm Hg90/60\text{ mm Hg}, pulse is 118/min118/\text{min}, and respirations are 26/min26/\text{min}. Physical examination reveals dry mucous membranes, decreased skin turgor, and a diffusely tender abdomen without rebound or guarding.

Laboratory studies show the following:
Serum sodium: 142 mEq/L142\text{ mEq/L}
Serum potassium: 3.2 mEq/L3.2\text{ mEq/L}
Serum chloride: 92 mEq/L92\text{ mEq/L}
Serum bicarbonate: 14 mEq/L14\text{ mEq/L}
Blood glucose: 550 mg/dL550\text{ mg/dL}
Serum blood urea nitrogen: 45 mg/dL45\text{ mg/dL}
Serum creatinine: 1.8 mg/dL1.8\text{ mg/dL}

Assuming a normal serum anion gap of 12 mEq/L12\text{ mEq/L} and a normal serum bicarbonate of 24 mEq/L24\text{ mEq/L}, what is this patient's delta-delta ratio (ΔAG/ΔHCO3−\Delta\text{AG} / \Delta\text{HCO}_3^-)?

Show answer & explanation

Answer: 2.4

Answer

The patient's delta-delta ratio is 2.4.
This patient presents with diabetic ketoacidosis (DKA), which causes a high anion gap metabolic acidosis (HAGMA). He also has a history of severe vomiting, which typically causes a metabolic alkalosis due to loss of gastric hydrochloric acid. To uncover this mixed disorder, the delta-delta ratio is calculated. The measured anion gap is 142−(92+14)=36 mEq/L142 - (92 + 14) = 36\text{ mEq/L}. The change in the anion gap (ΔAG\Delta\text{AG}) is 36−12=24 mEq/L36 - 12 = 24\text{ mEq/L}. The change in bicarbonate (ΔHCO3−\Delta\text{HCO}_3^-) is 24−14=10 mEq/L24 - 14 = 10\text{ mEq/L}. The delta-delta ratio is 24/10=2.424 / 10 = 2.4. In a pure HAGMA, the drop in bicarbonate should roughly equal the rise in the anion gap (ratio of 1.01.0 to 2.02.0). A ratio greater than 2.02.0 confirms that the bicarbonate has not dropped as much as expected, indicating the presence of a concurrent metabolic alkalosis, consistent with his history of vomiting.

Step-by-Step Solution

1
Calculate the patient's measured serum anion gap.
AG=142−(92+14)=36 mEq/L\text{AG} = 142 - (92 + 14) = 36\text{ mEq/L}
Calculating the anion gap is the first step in analyzing any acid-base disorder to determine if unmeasured anions are present.
2
Calculate the change in anion gap (ΔAG\Delta\text{AG}).
ΔAG=36−12=24 mEq/L\Delta\text{AG} = 36 - 12 = 24\text{ mEq/L}
This value represents the excess unmeasured anions (such as ketones) added to the blood.
3
Calculate the change in serum bicarbonate (ΔHCO3−\Delta\text{HCO}_3^-).
ΔHCO3−=24−14=10 mEq/L\Delta\text{HCO}_3^- = 24 - 14 = 10\text{ mEq/L}
This value represents how much bicarbonate was consumed to buffer the excess acid.
4
Calculate the delta-delta ratio.
ΔRatio=2410=2.4\Delta\text{Ratio} = \frac{24}{10} = 2.4
The ratio of ΔAG\Delta\text{AG} to ΔHCO3−\Delta\text{HCO}_3^- reveals whether the change in the anion gap corresponds to the drop in bicarbonate. A ratio greater than 2.0 indicates an underlying concurrent metabolic alkalosis.

Key Concept

The delta-delta ratio is used to identify mixed acid-base disorders in the presence of a high anion gap metabolic acidosis. A ratio greater than 2.0 indicates a concurrent metabolic alkalosis.
Question 1788Question →

A 72-year-old woman is brought to the clinic by her daughter due to progressive forgetfulness, irritability, and unsteadiness on her feet over the past 6 months. Her past medical history is significant for hypothyroidism and type 2 diabetes mellitus, which have been managed with levothyroxine and metformin for the last 8 years. Vital signs are within normal limits. Neurological examination reveals a broad-based gait, decreased vibratory sensation in the distal lower extremities bilaterally, and a positive Romberg sign. Deep tendon reflexes are 1+ at the ankles and 2+ at the patellae. Laboratory studies show:

Hemoglobin: 10.2 g/dL
Mean corpuscular volume (MCV): 108 fL
Platelets: 140,000/mm³
Serum vitamin B12: 245 pg/mL (normal: 200-900 pg/mL)
Serum folate: 14 ng/mL (normal: > 4.0 ng/mL)
Thyroid-stimulating hormone (TSH): 2.4 µU/mL

Which of the following is the most appropriate next step in the diagnosis of this patient's condition?

Show answer & explanation

Answer: Measurement of serum methylmalonic acid level

Answer

Measurement of serum methylmalonic acid level is the most appropriate next step to confirm tissue-level vitamin B12 deficiency in a patient with borderline serum levels.
The patient's presentation of macrocytic anemia, cognitive impairment, and dorsal column signs (decreased vibratory sense, positive Romberg sign) strongly suggests vitamin B12 (cobalamin) deficiency. Her prolonged use of metformin is a well-known risk factor for decreased ileal absorption of vitamin B12. When evaluating suspected B12 deficiency, the initial screening test is a serum vitamin B12 level. However, up to 30% of patients with true tissue deficiency may have levels strictly in the borderline or low-normal range (200-300 pg/mL). In such cases, the next best step is to measure serum methylmalonic acid (MMA). Vitamin B12 is a required cofactor for the enzyme methylmalonyl-CoA mutase, which converts methylmalonyl-CoA to succinyl-CoA. When B12 is deficient, this pathway is blocked, leading to an accumulation of MMA. Therefore, an elevated MMA level confirms a tissue-level B12 deficiency with high sensitivity and specificity.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has macrocytic anemia, peripheral neuropathy with dorsal column involvement, and cognitive changes, suggesting vitamin B12 deficiency. Her long-term metformin use is a key risk factor for malabsorption.
Identifying the clinical syndrome and recognizing risk factors guides the diagnostic workup.
2
Interpret the serum vitamin B12 level.
The serum B12 level is 245 pg/mL, which falls into the borderline or low-normal range (200-300 pg/mL).
A borderline level does not definitively confirm or rule out a tissue-level deficiency, necessitating further testing.
3
Select the appropriate confirmatory diagnostic test.
Methylmalonic acid (MMA) testing is chosen because it accumulates exclusively in vitamin B12 deficiency, making it highly sensitive and specific.
Vitamin B12 is an essential cofactor for the conversion of methylmalonyl-CoA to succinyl-CoA. In deficiency states, the substrate MMA builds up.

Key Concept

In patients with clinical manifestations of vitamin B12 deficiency but borderline serum B12 levels (200-300 pg/mL), a serum methylmalonic acid (MMA) level should be obtained to definitively confirm the diagnosis.
Estimated Time:1m 15s
Question 1789Question →

A 52-year-old woman comes to the clinic due to a 4-month history of progressively worsening shortness of breath and fatigue. She has a 12-year history of limited cutaneous systemic sclerosis, which has primarily manifested as Raynaud phenomenon, sclerodactyly, and cutaneous telangiectasias. She does not have a cough, fever, orthopnea, or lower extremity swelling. Vital signs are within normal limits. On physical examination, the lungs are clear to auscultation bilaterally. Cardiac examination reveals a prominently loud pulmonic component of the second heart sound (P2) and a right ventricular heave. There are no murmurs or gallops. Pulmonary function testing reveals the following:

ParameterPatient Value
FEV182%82\% of predicted
FVC85%85\% of predicted
FEV1/FVC ratio80%80\%
DLCO40%40\% of predicted

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Transthoracic echocardiography

Answer

Transthoracic echocardiography is the most appropriate next step to screen for pulmonary arterial hypertension.
The correct answer is transthoracic echocardiography. This patient with limited cutaneous systemic sclerosis (CREST syndrome) presents with progressive dyspnea, fatigue, and physical exam findings of right heart strain (a loud pulmonic component of the second heart sound and a right ventricular heave). Furthermore, her pulmonary function tests (PFTs) demonstrate an isolated decrease in the diffusing capacity for carbon monoxide (DLCO) with preserved forced vital capacity (FVC). This clinical picture is highly suggestive of pulmonary arterial hypertension (PAH), which is a common and severe complication of limited cutaneous systemic sclerosis caused by intimal hyperplasia of the pulmonary arteries. Transthoracic echocardiography is the most appropriate initial noninvasive screening test for PAH to estimate pulmonary artery pressures and assess right ventricular function. If echocardiography indicates PAH, a right heart catheterization is required for a definitive diagnosis.

Step-by-Step Solution

1
Analyze the patient's underlying disease and clinical presentation.
The patient has limited cutaneous systemic sclerosis and presents with progressive dyspnea and signs of right heart strain (loud P2, right ventricular heave).
Identifying the clinical syndrome and its known associated complications is essential for formulating a focused differential diagnosis.
2
Interpret the pulmonary function tests (PFTs).
PFTs show normal spirometry (FVC > 80%80\%) but an isolated, significantly reduced diffusing capacity for carbon monoxide (DLCO).
PFTs help differentiate between the two major pulmonary complications of systemic sclerosis: interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH).
3
Determine the most appropriate diagnostic evaluation based on the suspected etiology.
Transthoracic echocardiography should be ordered as the next step.
In a patient with suspected PAH, echocardiography is the initial screening test of choice to evaluate right ventricular pressures before proceeding to definitive right heart catheterization.

Key Concept

Patients with limited cutaneous systemic sclerosis are at high risk for pulmonary arterial hypertension (PAH), which presents with signs of right heart failure and an isolated reduction in DLCO on pulmonary function testing. Transthoracic echocardiography is the initial screening test of choice.
Estimated Time:1m 30s
Question 1790Question →

An 82-year-old woman is brought to the emergency department from a skilled nursing facility due to a 2-day history of worsening confusion and agitation. She has a medical history of moderate Alzheimer dementia, type 2 diabetes mellitus, hypertension, and urge urinary incontinence. Two weeks ago, she was evaluated for worsening incontinence, and oral oxybutynin was added to her regimen. She cannot provide a reliable history, but the facility staff reports no observed coughing, vomiting, diarrhea, or signs of pain during urination. The staff did note that her urine has been cloudy and malodorous for the past 3 days.

Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 138/84 mmHg138/84\text{ mmHg}, pulse 88/min88/\text{min}, and respiratory rate 16/min16/\text{min}. Oxygen saturation is 98%98\% on room air. The patient is disoriented to time and place and frequently picks at her clothing. The abdomen is soft, non-tender, and without suprapubic distension. Bilateral costovertebral angle percussion elicits no reaction.

Laboratory evaluation shows a leukocyte count of 8,500/mm38,500/\text{mm}^3, serum sodium of 138 mEq/L138\text{ mEq/L}, serum creatinine of 1.0 mg/dL1.0\text{ mg/dL}, and blood glucose of 115 mg/dL115\text{ mg/dL}. Urinalysis obtained via straight catheterization reveals:

Color: Yellow, cloudy
Specific gravity: 1.0181.018
Leukocyte esterase: Positive
Nitrites: Positive
WBCs: 30-40/hpf30\text{-}40/\text{hpf}
RBCs: 0-2/hpf0\text{-}2/\text{hpf}
Bacteria: Many

A urine culture is sent to the laboratory. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Withhold antimicrobial therapy and evaluate for alternative etiologies of altered mental status

Answer

Withhold antimicrobial therapy and evaluate for alternative etiologies of altered mental status
The most appropriate next step is to withhold antimicrobial therapy and evaluate for alternative etiologies of her altered mental status. This patient presents with acute delirium and a positive urinalysis. However, up to 50%50\% of elderly female nursing home residents have asymptomatic bacteriuria (ASB). According to current infectious disease guidelines, ASB should not be screened for or treated, even in older patients presenting with altered mental status, provided they lack systemic signs of infection (e.g., fever, hemodynamic instability, marked leukocytosis) and focal genitourinary symptoms (e.g., dysuria, suprapubic pain, costovertebral angle tenderness). Furthermore, cloudy and malodorous urine does not constitute a focal symptom and is not an indication for antibiotics. Treating ASB does not improve clinical outcomes and increases the risk of antimicrobial resistance, adverse drug reactions, and *Clostridioides difficile* infection. Instead of anchoring on the positive urinalysis, clinicians should search for alternative causes of delirium. In this patient, the recent initiation of oxybutynin (a medication with strong anticholinergic properties) is the highly likely culprit for her acute cognitive decline.

Step-by-Step Solution

1
Evaluate the patient's vital signs and physical examination for evidence of a true symptomatic infection.
The patient has altered mental status but no localizing genitourinary symptoms (e.g., suprapubic pain, costovertebral angle tenderness) or systemic signs of infection (e.g., fever, tachycardia, marked leukocytosis).
Distinguishing true infection from asymptomatic colonization requires assessing for systemic and localizing clinical signs, particularly in elderly patients with baseline cognitive impairment.
2
Analyze the urinalysis findings in the context of the clinical presentation.
The urinalysis is positive for leukocytes, nitrites, and bacteria, confirming the presence of bacteriuria.
While the urinalysis shows bacteriuria, cloudy and malodorous urine alone without systemic or localizing inflammatory signs does not diagnose a symptomatic infection in this demographic.
3
Identify alternative non-infectious causes for the patient's acute delirium.
The patient was recently started on oxybutynin, an antispasmodic medication with strong anticholinergic properties that carries a high risk of inducing acute delirium in the elderly.
Recognizing adverse medication effects is crucial to avoid inappropriate anchoring on a false-positive infectious workup.
4
Determine the most appropriate management plan based on antimicrobial stewardship guidelines.
Antibiotics are withheld, and a workup for alternative etiologies (including addressing the anticholinergic medication) is pursued.
Treating asymptomatic bacteriuria in the elderly does not improve clinical outcomes and inappropriately promotes antimicrobial resistance.

Key Concept

In elderly patients with altered mental status but no systemic or focal genitourinary symptoms, a positive urinalysis typically represents asymptomatic bacteriuria and should not be treated with antibiotics. Alternative causes for delirium, such as anticholinergic medications, should be aggressively investigated.
Question 1791Question →

A 24-year-old woman is brought to the endocrinology clinic by her sister due to distressing changes in her appearance over the past three months. She has developed thick, dark hair on her chin and chest, and she notes her voice has become noticeably deeper. Her menstrual periods, previously regular, have been absent for four months. She takes no medications. Her blood pressure is 118/76 mmHg and her body mass index is 23 kg/m223 \text{ kg/m}^2. Physical examination reveals severe hirsutism, cystic acne on her back, temporal hair thinning, and clitoromegaly. A bedside pelvic ultrasound demonstrates multiple small follicles peripherally arranged in both ovaries. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate

Answer

Measurement of serum testosterone and dehydroepiandrosterone sulfate
The correct answer identifies the essential initial biochemical workup for suspected androgen-secreting tumors. Rapid-onset virilization (deep voice, clitoromegaly) requires measuring testosterone (to check for ovarian tumors) and DHEAS (to check for adrenal tumors) to guide subsequent targeted imaging.

Step-by-Step Solution

1
Analyze the patient's symptoms and time course.
The patient has a 3-month history of rapid-onset hyperandrogenism with signs of true virilization, including a deepened voice, temporal balding, and clitoromegaly.
Differentiating between simple hirsutism and frank virilization is the critical first step in evaluating hyperandrogenism.
2
Differentiate benign etiologies from potential malignancies.
Benign causes like PCOS present with a gradual onset of hirsutism. Rapid-onset virilization is a red flag that strongly suggests an androgen-secreting tumor.
Recognizing red flags prevents inappropriate symptomatic treatment and prompts urgent diagnostic workup.
3
Determine the appropriate diagnostic sequence for a suspected androgen-secreting tumor.
Biochemical testing with serum testosterone and DHEAS must precede imaging to localize the tumor's origin (ovarian vs. adrenal).
Elevated testosterone points to an ovarian source (indicating pelvic ultrasound), whereas elevated DHEAS points to an adrenal source (indicating adrenal CT).

Key Concept

Rapid-onset virilization in a female patient requires immediate evaluation for an androgen-secreting tumor by measuring serum testosterone and DHEAS levels to localize the source before imaging.
Question 1792Question →

A 4242-year-old man visits the outpatient physician reporting a 44-month history of profound tiredness, reduced sexual desire, and frequent morning headaches. Over the last several weeks, he has experienced near-miss accidents while driving because he did not see cars in the adjacent lanes. Vital signs are within normal limits. Laboratory studies reveal:

* Thyroid-stimulating hormone (TSH): 1.11.1 mU/L (Normal: 0.50.5 - 5.05.0 mU/L)
* Free thyroxine (T4): 0.40.4 ng/dL (Normal: 0.90.9 - 1.71.7 ng/dL)

Which of the following is the most likely underlying cause of this patient's presentation?

Show answer & explanation

Answer: Compression of anterior pituitary cells by an expanding lesion

Answer

Compression of anterior pituitary cells by an expanding lesion
The patient presents with classic signs of a pituitary macroadenoma, including mass effect (morning headaches and bitemporal hemianopsia leading to driving accidents) and hypopituitarism (decreased libido from secondary hypogonadism). The laboratory findings confirm central hypothyroidism, characterized by a low free T4 and an inappropriately normal TSH. A structurally normal pituitary gland would respond to a low free T4 by drastically increasing TSH secretion. The failure to do so indicates central pathology, most likely an expanding sellar lesion compressing the normal thyrotroph cells.

Step-by-Step Solution

1
Analyze the patient's clinical symptoms.
The patient has symptoms of hypothyroidism (fatigue), hypogonadism (decreased sexual desire), and a sellar mass effect (morning headaches, bitemporal hemianopsia affecting driving).
To identify the clinical syndrome pointing to the anatomic location of the pathology.
2
Interpret the thyroid function laboratory results.
The free T4 is distinctly low (0.40.4 ng/dL), but the TSH is normal (1.11.1 mU/L) rather than elevated.
To differentiate between primary thyroid failure and central (secondary) hypothyroidism.
3
Correlate laboratory findings with the clinical presentation.
The inappropriately normal TSH in the setting of low free T4 confirms central hypothyroidism. This aligns perfectly with the mass effect symptoms caused by a pituitary macroadenoma compressing both the optic chiasm and the normal anterior pituitary tissue.
To synthesize all data points and determine the underlying pathophysiologic mechanism.

Key Concept

Central hypothyroidism presents with a low free T4 and an inappropriately normal or low TSH, often accompanied by other signs of hypopituitarism and mass effect if caused by a pituitary adenoma.
Question 1793Question →

A 4242-year-old man comes to the clinic complaining of worsening anxiety, excessive sweating, and a 55-kg (1111-lb) weight loss over the past three months despite an increased appetite. He has no significant past medical history and takes no medications. Vital signs show a blood pressure of 142/82142/82 mmHg and a heart rate of 110110/min. Physical examination reveals a restless patient with a fine resting tremor of the hands, warm and diaphoretic skin, and a palpable, diffusely enlarged, non-tender thyroid gland without discrete nodules. No exophthalmos or pretibial myxedema is noted.

Laboratory evaluation reveals the following:

TestResultReference Range
Thyroid-stimulating hormone (TSH)2.82.8 μ\muU/mL0.50.5 - 5.05.0 μ\muU/mL
Free thyroxine (T4)3.13.1 ng/dL0.90.9 - 1.71.7 ng/dL
Total triiodothyronine (T3)245245 ng/dL8080 - 200200 ng/dL

Based on the clinical and laboratory findings, which of the following is the most appropriate next diagnostic step?

Show answer & explanation

Answer: Magnetic resonance imaging of the pituitary gland

Answer

Magnetic resonance imaging of the pituitary gland is the correct next step because the patient's elevated thyroid hormones paired with an inappropriately normal TSH indicate a central cause of hyperthyroidism, most likely a TSH-secreting pituitary adenoma.
The correct answer involves recognizing the classic laboratory pattern for secondary (central) hyperthyroidism. In a normal physiologic state, an elevation in free T4 and T3 exerts robust negative feedback on the anterior pituitary, suppressing TSH production to near-zero levels. When a patient presents with clear thyrotoxicosis and elevated peripheral thyroid hormones, a TSH level that is within the normal range (2.82.8 µU/mL) is highly abnormal and termed 'inappropriately normal.' This points directly to autonomous TSH production, most commonly from a TSH-secreting pituitary adenoma (TSH-oma). The definitive next step to evaluate for a central structural lesion is magnetic resonance imaging (MRI) of the pituitary gland.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits classic signs of thyrotoxicosis: weight loss, anxiety, diaphoresis, tachycardia, tremor, and a diffuse goiter.
Establishing the clinical state directs the interpretation of the subsequent biochemical data.
2
Interpret the thyroid function tests within the context of the hypothalamic-pituitary-thyroid axis.
Free T4 and Total T3 are significantly elevated, confirming clinical hyperthyroidism. However, the TSH is within the normal reference range (2.82.8 µU/mL).
In primary hyperthyroidism (e.g., Graves' disease), high levels of T4 and T3 exert negative feedback on the pituitary, causing TSH to be profoundly suppressed (usually < 0.050.05 µU/mL). A normal TSH in the face of elevated T4/T3 is 'inappropriately normal'.
3
Determine the etiology based on the 'inappropriately normal' TSH pattern.
This pattern indicates secondary (central) hyperthyroidism, most commonly caused by a TSH-secreting pituitary adenoma (TSH-oma).
The pituitary gland is failing to suppress TSH production despite massive negative feedback from circulating thyroid hormones, indicating autonomous TSH production.
4
Select the appropriate diagnostic modality to confirm the suspected etiology.
An MRI of the pituitary gland is indicated.
MRI is the imaging modality of choice to visualize and delineate the size and extent of a pituitary macroadenoma or microadenoma responsible for the autonomous TSH secretion.

Key Concept

An elevated free T4 level paired with an inappropriately normal or elevated TSH indicates secondary (central) hyperthyroidism. The most common cause is a TSH-secreting pituitary adenoma, which requires an MRI of the pituitary gland for diagnosis.
Question 1794Question →

A 3434-year-old woman comes to the clinic for a 66-week follow-up visit. She was diagnosed with Graves disease after presenting with a 44-kg (8.88.8-lb) weight loss, frequent palpitations, and heat intolerance. At the time of diagnosis, her thyroid-stimulating hormone (TSH) level was <0.01<0.01 μ\mu U/mL and her free thyroxine (T4) level was 3.83.8 ng/dL. She was initiated on methimazole and propranolol. Today, the patient reports that she feels much better; her palpitations have resolved, she is sleeping well, and her weight has remained stable for the past three weeks. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 118/74118/74 mm Hg, and pulse 7272/min. Physical examination shows a mild, non-tender thyromegaly. She has no tremors. Laboratory evaluation today shows:

TestPatient ResultReference Range
TSH<0.01<0.01 μ\muU/mL0.5−5.00.5 - 5.0 μ\muU/mL
Free T41.31.3 ng/dL0.9−1.70.9 - 1.7 ng/dL
Total T3120120 ng/dL80−20080 - 200 ng/dL

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Continue the current methimazole dosage

Answer

Continue the current methimazole dosage
The correct answer is to continue the current methimazole dosage. This patient has achieved clinical euthyroidism (resolution of symptoms, normal heart rate) and biochemical euthyroidism (normalized Free T4 and Total T3) on her current regimen. In the initial months of treating overt hyperthyroidism, the pituitary thyrotrophs remain functionally suppressed due to prolonged prior exposure to high circulating thyroid hormone levels. As a result, TSH levels typically remain low for several months and do not accurately reflect the patient's current metabolic state. During this 'pituitary lag' phase, antithyroid drug dosages must be titrated strictly based on Free T4 and Total T3 levels. Because her peripheral thyroid hormones are well within the normal limits, continuing the current dosage is the most appropriate next step.

Step-by-Step Solution

1
Assess the patient's clinical status.
Symptoms have resolved, weight is stable, and heart rate is normal.
Clinical presentation guides the interpretation of laboratory values and confirms a positive response to therapy.
2
Evaluate the current thyroid hormone levels.
Free T4 and Total T3 have normalized, but TSH remains suppressed (<0.01 μU/mL).
To determine the biochemical response to the initial methimazole therapy after 6 weeks.
3
Interpret the discordant laboratory findings.
The suppressed TSH represents a normal physiologic lag in pituitary thyrotroph recovery following prolonged hyperthyroidism, not treatment failure.
TSH can remain suppressed for 3-6 months and is not reliable for early dose titration in hyperthyroidism.
4
Determine the next step in management.
The current methimazole dosage should be maintained.
The patient is biochemically and clinically euthyroid based on Free T4/T3 levels, requiring no antithyroid dose adjustment at this time.

Key Concept

During the first few months of treating hyperthyroidism, TSH levels remain suppressed due to a physiological lag in pituitary recovery. Antithyroid drug dosages must be titrated based on Free T4 and Total T3 levels rather than TSH.
Question 1795Question →

A 54-year-old man is evaluated in the hospital for decreased urine output. He was admitted 7 days ago for infective endocarditis and has been receiving intravenous vancomycin and gentamicin. Over the past 24 hours, his urine output has dropped to 300 mL. His vital signs are within normal limits and he appears euvolemic on examination. Laboratory studies show the following:

Laboratory ParameterSerumUrine
Sodium140 mEq/L70 mEq/L
Potassium5.2 mEq/L25 mEq/L
Creatinine4.0 mg/dL50 mg/dL
Urea nitrogen (BUN)40 mg/dL-
Osmolality290 mOsm/kg H₂O310 mOsm/kg H₂O

Microscopic urinalysis reveals muddy brown granular casts.

Based on the provided laboratory findings, what is this patient's fractional excretion of sodium (FeNaFe_{Na})? (Express your answer as a percentage)

Show answer & explanation

Answer: 4

Answer

4.0
The fractional excretion of sodium (FeNaFe_{Na}) measures the percentage of filtered sodium that is ultimately excreted in the urine. It is calculated using the formula: FeNa=UNa×PCrPNa×UCr×100Fe_{Na} = \frac{U_{Na} \times P_{Cr}}{P_{Na} \times U_{Cr}} \times 100. Plugging in the correctly extracted values from the table (UNa=70U_{Na} = 70, PCr=4.0P_{Cr} = 4.0, PNa=140P_{Na} = 140, UCr=50U_{Cr} = 50) yields 2807000×100=4.0%\frac{280}{7000} \times 100 = 4.0\%. A value greater than 2% in the setting of oliguria is highly suggestive of intrinsic acute kidney injury, specifically acute tubular necrosis (ATN). This correlates perfectly with the patient's history of aminoglycoside (gentamicin) use, isotonic urine (osmolality ~300 mOsm/kg), and the pathognomonic finding of muddy brown granular casts on urinalysis.

Step-by-Step Solution

1
Recall the Fractional Excretion of Sodium (FeNa) formula.
FeNa=UNa×PCrPNa×UCr×100Fe_{Na} = \frac{U_{Na} \times P_{Cr}}{P_{Na} \times U_{Cr}} \times 100
This formula normalizes sodium excretion to the glomerular filtration rate, helping differentiate the etiology of acute kidney injury.
2
Identify the correct serum and urine values from the vignette's data table.
UNaU_{Na} = 70 mEq/L, PCrP_{Cr} = 4.0 mg/dL, PNaP_{Na} = 140 mEq/L, UCrU_{Cr} = 50 mg/dL.
Careful extraction prevents using incorrect parameters such as BUN or potassium, which act as distractors.
3
Perform the multiplication for the numerator and denominator.
Numerator = 280, Denominator = 7000.
70×4.0=28070 \times 4.0 = 280 and 140×50=7000140 \times 50 = 7000.
4
Divide the numerator by the denominator and convert to a percentage.
280/7000=0.04280 / 7000 = 0.04, which translates to 4.0%.
This yields the final diagnostic percentage, which is > 2%, consistent with acute tubular necrosis.

Key Concept

The Fractional Excretion of Sodium (FeNa) is calculated to differentiate prerenal azotemia (FeNa < 1%) from intrinsic acute kidney injury (FeNa > 2%).
Question 1796Question →

A 65-year-old man with a history of metastatic prostate cancer presents to the emergency department reporting severe, progressively worsening back pain for the past two weeks. This morning, he developed new-onset bilateral leg weakness and urinary retention. Physical examination reveals 3/5 motor strength in both lower extremities, patellar hyperreflexia, and decreased sensation to pinprick below the umbilicus. Anal sphincter tone is decreased. Arrange the following interventions in the most appropriate chronological sequence for the optimal management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first administer intravenous corticosteroids, followed by obtaining an urgent spinal MRI, then consulting oncology specialties, and finally proceeding with definitive decompressive therapy.
Malignant epidural spinal cord compression is a severe oncologic emergency. The immediate priority is administering high-dose intravenous corticosteroids (e.g., dexamethasone) to reduce vasogenic edema and preserve neurologic function. This must be done empirically based on clinical suspicion alone, before imaging is obtained. Once steroids are administered, an urgent MRI of the entire spine is required to confirm the diagnosis, delineate the extent of the disease, and check for multiple levels of compression. Following radiographic confirmation, surgical and radiation oncology services are consulted to provide definitive treatment via decompressive laminectomy or external beam radiation therapy, depending on patient stability and tumor radiosensitivity.

Step-by-Step Solution

1
Recognize the signs of epidural spinal cord compression (ESCC).
Identify this as an acute oncologic emergency requiring immediate intervention.
The combination of back pain, motor weakness, sensory level, and bowel/bladder dysfunction in a patient with known malignancy is highly suggestive of ESCC.
2
Initiate empiric high-dose intravenous corticosteroids.
Reduces peritumoral vasogenic edema.
Immediate reduction in swelling relieves pressure on the spinal cord, preserving neurologic function while awaiting definitive diagnosis.
3
Perform whole-spine MRI.
Confirms the diagnosis and localizes the exact site(s) of compression.
Accurate radiographic mapping is mandatory before planning targeted radiation or surgical interventions.
4
Determine and execute definitive management.
Long-term relief of spinal cord compression.
Surgery or radiation therapy addresses the underlying tumor mass causing the mechanical obstruction.

Key Concept

Stepwise management of malignant epidural spinal cord compression.
Question 1797Question →

Match each rheumatologic autoantibody profile with its most characteristic clinical presentation.

Click a left item, then click its matching right item

Items

Anti-Jo-1 antibody
Anti-centromere antibody
Anti-U1-ribonucleoprotein (RNP) antibody
Anti-topoisomerase I (anti-Scl-70) antibody

Matches

Show answer & explanation

Answer

Anti-Jo-1 matches with proximal muscle weakness and mechanic's hands. Anti-centromere matches with distal cutaneous thickening and esophageal dysmotility. Anti-U1-RNP matches with polyarthritis and overlapping lupus/sclerosis features. Anti-topoisomerase I matches with extensive trunk/proximal cutaneous thickening and pulmonary fibrosis.
Each rheumatologic condition has a highly specific autoantibody profile. Antisynthetase syndrome classically presents with anti-Jo-1 positivity, interstitial lung disease, and mechanic's hands. Mixed connective tissue disease requires the presence of anti-U1-RNP and features a combination of lupus, myositis, and systemic sclerosis signs. The subtypes of systemic sclerosis are differentiated clinically by the extent of skin involvement (limited vs. diffuse) and serologically by their respective markers (anti-centromere vs. anti-topoisomerase I).

Step-by-Step Solution

1
Analyze the autoantibodies associated with systemic sclerosis subtypes.
Anti-centromere corresponds to limited systemic sclerosis (distal extremity involvement), whereas Anti-topoisomerase I (anti-Scl-70) corresponds to diffuse systemic sclerosis (proximal/trunk involvement).
Differentiating these subtypes relies heavily on the pattern of skin involvement and specific serologies.
2
Identify the distinct markers for mixed connective tissue disease (MCTD) and inflammatory myopathies.
Anti-U1-RNP is the defining antibody for MCTD. Anti-Jo-1 is specific for antisynthetase syndrome.
Recognizing the pathognomonic presentation of antisynthetase syndrome (mechanic's hands, myositis) and MCTD (overlapping features) isolates the remaining pairings.

Key Concept

Clinical correlation of specific autoantibodies in systemic autoimmune and connective tissue diseases
Estimated Time:1m 0s
Question 1798Question →

Emergency medical services bring a 68-year-old male resident of a skilled nursing facility to the hospital for evaluation of profound lethargy and confusion. According to the transfer paperwork, the patient has a history of severe chronic obstructive pulmonary disease requiring continuous home oxygen, as well as hypertension and type 2 diabetes mellitus. Over the past four days, he has experienced up to 10 large-volume, watery bowel movements daily following a recent course of oral clindamycin. On arrival, his blood pressure is 98/60 mm Hg, heart rate is 114/min, and respiratory rate is 26/min. Physical examination reveals dry mucous membranes, decreased skin turgor, and diffuse bilateral wheezing.

Laboratory results are as follows:
Serum sodium: 138 mEq/L
Serum potassium: 3.2 mEq/L
Serum chloride: 115 mEq/L
Serum bicarbonate: 12 mEq/L
Blood urea nitrogen: 48 mg/dL
Serum creatinine: 1.8 mg/dL

Arterial blood gas (room air):
pH: 7.12
pCO2: 38 mm Hg
pO2: 58 mm Hg

Which of the following best characterizes this patient's acid-base status?

Show answer & explanation

Answer: Mixed non-anion gap metabolic acidosis and respiratory acidosis

Answer

Mixed non-anion gap metabolic acidosis and respiratory acidosis
The correct diagnosis requires a systematic approach to acid-base interpretation. First, the acidemia (pH 7.12) is driven by a low bicarbonate (12 mEq/L), establishing a primary metabolic acidosis. Next, the anion gap is calculated as 138−(115+12)=11138 - (115 + 12) = 11 mEq/L, indicating a non-anion gap metabolic acidosis caused by massive bicarbonate loss from diarrhea. Finally, Winter's formula (Expected pCO2=(1.5×HCO3−)+8±2Expected\ pCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2) is used to evaluate respiratory compensation. The expected pCO2pCO_2 is 26±226 \pm 2 mm Hg. The patient's actual pCO2pCO_2 of 38 mm Hg is significantly higher than this target range. This disparity reveals that the patient has a concurrent respiratory acidosis. His severe COPD prevents him from mounting the necessary compensatory hyperventilation required by his severe metabolic acidosis.

Step-by-Step Solution

1
Evaluate the patient's overall acid-base status by assessing the pH.
The pH of 7.12 indicates significant acidemia.
Establishing whether the patient is acidemic or alkalemic is the first step in interpreting an arterial blood gas.
2
Identify the primary disturbance responsible for the acidemia.
The serum bicarbonate is low (12 mEq/L), indicating a primary metabolic acidosis.
In acidemia, a low bicarbonate indicates metabolic acidosis, whereas a high pCO2 indicates respiratory acidosis. Here, the profound drop in bicarbonate is the primary driver.
3
Calculate the serum anion gap to classify the metabolic acidosis.
The anion gap is calculated as: AG=Na+−(Cl−+HCO3−)AG = Na^+ - (Cl^- + HCO_3^-). Here, AG=138−(115+12)=11AG = 138 - (115 + 12) = 11 mEq/L.
An anion gap of 11 mEq/L falls within the normal range (8-12 mEq/L), confirming a non-anion gap (hyperchloremic) metabolic acidosis, which aligns with his history of severe diarrhea.
4
Determine if the respiratory compensation is appropriate by applying Winter's formula.
Expected pCO2=(1.5×HCO3−)+8±2pCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2. Thus, expected pCO2=(1.5×12)+8=26±2pCO_2 = (1.5 \times 12) + 8 = 26 \pm 2 mm Hg.
Winter's formula calculates the precise pCO2pCO_2 range the lungs should achieve through compensatory hyperventilation in response to a metabolic acidosis.
5
Compare the actual measured pCO2pCO_2 against the expected pCO2pCO_2 range.
The actual pCO2pCO_2 (38 mm Hg) is significantly greater than the expected range (24-28 mm Hg).
Because the actual pCO2pCO_2 is higher than the physiological target, there is an uncompensated accumulation of CO2CO_2, representing a concomitant primary respiratory acidosis due to the patient's underlying severe COPD.

Key Concept

Patients with metabolic acidosis must be evaluated with Winter's formula to assess for mixed acid-base disorders; a 'normal' absolute pCO2 value (35-45 mm Hg) often masks a severe concomitant respiratory acidosis if the expected pCO2 is much lower.
Estimated Time:1m 30s
Question 1799Question →

A 45-year-old woman is found to have a palpable 2.5-cm nodule in the right lobe of her thyroid gland during a routine physical examination. Arrange the following steps in the correct chronological sequence for the standard diagnostic evaluation and management of this patient. Assume that her initial biochemical testing reveals a suppressed TSH level and subsequent imaging demonstrates a non-functioning nodule.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first measure TSH and perform a thyroid ultrasound, followed by a radionuclide thyroid scan (due to the suppressed TSH), then a fine-needle aspiration (FNA) biopsy (due to the non-functioning nature of the nodule), and finally determine surgical versus surveillance management based on cytology.
The standard evaluation of a thyroid nodule strictly begins with a serum TSH and ultrasound. If the TSH is low, a radionuclide scan is required to check for autonomous function. A 'hot' nodule is treated for hyperthyroidism, while a 'cold' nodule requires an FNA biopsy due to malignancy risk. Finally, the FNA cytology results guide definitive management.

Step-by-Step Solution

1
Identify the standard initial evaluation for a newly discovered palpable thyroid nodule.
TSH measurement and a thyroid ultrasound are always the first steps in the algorithm.
TSH determines if the nodule might be hyperfunctioning, while ultrasound assesses the size and identifies suspicious sonographic features.
2
Determine the next indicated step for a patient presenting with a suppressed (low) TSH.
A radionuclide thyroid scan is indicated.
A low TSH suggests hyperthyroidism. The radionuclide scan differentiates between a 'hot' (hyperfunctioning) nodule, which is rarely malignant, and a 'cold' (non-functioning) nodule.
3
Determine the appropriate diagnostic procedure for a 'cold' nodule.
Fine-needle aspiration (FNA) biopsy is performed.
Non-functioning ('cold') nodules have an increased risk of malignancy and require direct cytological evaluation to rule out thyroid cancer.
4
Establish the final step in the clinical pathway.
Definitive management is chosen based on FNA cytology.
The cytological results (e.g., benign, malignant, indeterminate) dictate whether the patient undergoes surgical resection or routine ultrasonographic observation.

Key Concept

The diagnostic algorithm for a palpable thyroid nodule depends primarily on the initial serum TSH level; a low TSH warrants a radionuclide scan, and subsequent 'cold' nodules require FNA biopsy.
Question 1800Question →

Various parasitic infections require specific antimicrobial agents based on their pathogenesis and the patient's clinical syndrome. For each patient vignette described below, select the most appropriate definitive treatment regimen.

Click a left item, then click its matching right item

Items

A 45-year-old agricultural worker from South America presenting with progressive dysphagia, severe constipation, and right bundle branch block on electrocardiogram.
A 32-year-old male traveler presenting with painless terminal hematuria and chronic dysuria months after swimming in freshwater lakes in sub-Saharan Africa.
A 60-year-old immunosuppressed host on chronic systemic glucocorticoids who rapidly develops recurrent enteric gram-negative bacteremia and a rapidly advancing serpiginous perianal rash.
A 29-year-old immigrant from rural Central America presenting with new-onset focal seizures; brain magnetic resonance imaging shows multiple cysts with distinct internal dots (scolices).
A 35-year-old aid worker returning from South Asia presenting with weeks of irregular fever, profound weight loss, massive hepatosplenomegaly, and pancytopenia.

Matches

Show answer & explanation

Answer

The clinical presentations match with their respective targeted therapies: Chagas disease with benznidazole, urinary schistosomiasis with praziquantel, Strongyloides hyperinfection with ivermectin, neurocysticercosis with albendazole and dexamethasone, and visceral leishmaniasis with liposomal amphotericin B.
The correct matches align specific parasitic pathogen profiles with their guideline-directed therapies. Trypanosoma cruzi causes Chagas disease (cardiomyopathy, achalasia, megacolon) and is treated with benznidazole. Schistosoma haematobium causes urinary schistosomiasis and is treated with praziquantel. Strongyloides stercoralis can cause a hyperinfection syndrome in immunosuppressed hosts, treated with ivermectin. Taenia solium causes neurocysticercosis, which must be treated with both albendazole and corticosteroids like dexamethasone to prevent severe localized inflammation. Visceral leishmaniasis presents with systemic signs (fever, hepatosplenomegaly, pancytopenia) and is treated with liposomal amphotericin B.

Step-by-Step Solution

1
Analyze each vignette to identify the underlying parasitic pathogen based on geographic exposure and clinical findings.
Identified Trypanosoma cruzi, Schistosoma haematobium, Strongyloides stercoralis, Taenia solium, and Leishmania species respectively.
Accurate pathogen identification is required to select the targeted antimicrobial therapy.
2
Select the first-line pharmacotherapy for each identified organism.
Benznidazole (Chagas), Praziquantel (Schistosomiasis), Ivermectin (Strongyloides), Albendazole with dexamethasone (Neurocysticercosis), and Liposomal amphotericin B (Leishmaniasis).
Anti-parasitic agents are highly specific to the organism's class (e.g., nematodes vs. trematodes vs. protozoa) and clinical severity.
3
Match the clinical vignettes with their corresponding correct therapies.
All five clinical presentations are correctly paired with their definitive treatment regimens.
This completes the requirements of the matching task based on current infectious disease guidelines.

Key Concept

Diagnosis and targeted antimicrobial therapy for systemic and tissue-invasive parasitic infections.
PreviousPage 90 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 90 | Examkin